Dr. Anthony Jones

Dr. Antony Jones is a managing consultant at Broughton with over twenty-two years of multidisciplinary consulting experience preparing and critically assessing a broad range of toxicological, microbial and epidemiological studies. Dr. Jones has conducted human health risk assessments of multiple Electronic Nicotine Delivery systems (ENDS) and other tobacco products for inclusion in FDA Pre-Market Tobacco Applications (PMTA). He also has experience conducting ecological and microbial risk assessments, preparing regulatory submissions and communicating results to clients, community stakeholders and governmental agencies.

Jason Flora

Jason W. Flora, Ph.D., is an Associate Fellow, Scientific Strategy & Advocacy, Regulatory Affairs for Altria Client Services (ALCS) in Richmond, VA. In this role, he leads the strategic planning and integration of cross-functional teams of experts to develop the science and evidence for regulatory submissions for non-combustible tobacco products for Altria’s tobacco operating companies.

Dr. Flora has held a variety of positions within the Altria family of companies. Most recently, he served as Senior Principal Scientist where he led the science integration for Philip Morris USA with a focus on the scientific substantiation and regulatory requirements for Heated Tobacco Products (HTPs). He has also held the position of Senior Manager, Sensory and Analytical Sciences, where he led two teams of analytical scientists focusing on analytical constituent evaluations supporting analytical chemistry method development for regulatory reporting and product development. He has also held positions in the Health Science Research group within ALCS where he developed and led the Proteomics Research group and has worked in the External Scientific Communications group.

Dr. Flora served seven years as an adjunct faculty member at Virginia Commonwealth University teaching a graduate level chemistry course focused on Mass Spectrometry.

Before joining the Altria family of companies in 2002, Dr. Flora held a variety of positions including environmental chemist, manufacturing chemist/QA manager, and manager of the Mass Spectrometry Center for the Study of Biocomplexity at Virginia Commonwealth University.

Dr. Flora is currently the recipient of 16 U.S. patents. He has also co-authored more than 25 scientific peer-reviewed publications and more than 60 presentations in areas such as the scientific assessment of reduced risk tobacco products, biomarker discovery, analytical method development, aerosol chemical characterization, and small molecule structural confirmations.

PhD, Analytical Chemistry, Virginia Commonwealth University, Richmond, VA, 2002

MS, Analytical Chemistry, Virginia Commonwealth University, Richmond, VA, 2000 

BS, Chemistry, Hampden-Sydney College, Hampden-Sydney, VA, 1994

Fleur Besteman

Fleur is a spontaneous, open-minded, and compassionate professional who values sincerity, generosity, and openness. With a background in FinTech, she has transitioned from tech to commercial roles at Adyen. In her current sales position, she thrives on educating and challenging hotel businesses to embrace state-of-the-art technology in order to provide a seamless guest experience.

Juan Jose Llorente

Juan José Llorente has lead Adyen’s activity in Spain and Portugal since 2013 as Country Manager. His work has allowed the company to boost its presence in the Spanish e-commerce and retail market, increasing the client portfolio with companies from the fashion, hospitality and travel verticals. He has an extensive experience in the payments and e-commerce vertical, in which he has held different positions of responsibility in companies such as PayPal or Amadeus. Juan José developed his university studies in Spain, France and Germany, with an MBA from IESE and Northwestern University – Kellogg School of Management. He is passionate about languages, different, culturas, travel, family and sports.

Ryan Haynes

Ryan is a hotel technology marcomms consultant with over 15 years’ experience working with global systems and software in the sector. He is Managing Director of Haynes MarComs working with technology companies to bring clarity and opportunity for hotels in the journey of digitalisation.

As host of Travel Market Life podcast, Ryan explores technology and digital developments to support industry buyers in procurement and market management. Hoteliers’ Voice series explore how hotels are addressing key developments within their tech stacks.

 

Former broadcaster and PR consultant, Ryan supports businesses with engaging market engagement strategies to build profile and gain momentum. Ryan has worked with the likes of eRevMax, HomeAway, SIHOT, Pegasus, bd4travel, Sciant, Arvoia and Beonprice.

David Potter

David Potter has been in the Pharma Industry for the past 29 years. He is currently at Daiichi-Sankyo as a Director of Data Management responsible for the Specialty Medicine, Lab and Coding teams since October 2021.

Prior to Daiichi-Sankyo, Dave was at Kyowa Kirin USA Holdings, Inc. for 13 years serving in the Biometrics Group as the Head of Data Management and Programming. He supported the growth and development of the department as well as participating on various Regulatory inspections (MHRA, EMA and FDA) with many lessons learned as an SME and served as one of the companies Cultural Ambassadors.

Dave started his career at Merck & Company after graduating from Southern Connecticut State University and has experience across various roles in Drug Development and Data Management/Biometrics working in both CRO and Pharmaceutical companies.

Dave has been happily married for the past 25 years and has two children in college. He enjoys sports, spending time with his family, friends and is very active in his Church and community initiatives/activities.

Owen Corbin

Owen Corbin is an attorney admitted to the NC Bar (1996), CIPM, with more than 15 years of industry experience helping customers navigate a complex global regulatory landscape.  He joined IQVIA in 2012 and is currently Sr. Director, DCT Regulatory and Privacy for IQVIA Decentralized Clinical Trials.

Fabio Van Keulen

Fabio is a business developer within Siemens Smart Infrastructure taking care of premium customers operating in hospitality and Real Estate with a quantifiable and value-based approach to digitalization programs. He pursued International Business studies with focus on finance management. His professional career spanned from a global FMCG player towards IT-OT integration mastery at Siemens.